Homology Medicines, Inc.

Homology Medicines, Inc.verified

FIXX

Price:

$0.9347

Market Cap:

$36.42M

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, cardiac and skeletal muscle, and eye. Its lead product candidate is HMI-102, which is in ...[Read more]

Industry

Biotechnology

IPO Date

2018-03-28

Stock Exchange

NASDAQ

Ticker

FIXX

The Enterprise Value as of December 2025 (TTM) for Homology Medicines, Inc. (FIXX) is -1269685.00

According to Homology Medicines, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -1269685.00. This represents a change of -93.23% compared to the average of -18768105.03 of the last 4 quarters.

Homology Medicines, Inc. (FIXX) Historical Enterprise Value (quarterly & annually)

How has FIXX Enterprise Value performed in the past?

The mean historical Enterprise Value of Homology Medicines, Inc. over the last ten years is 371.71M. The current -1269685.00 Enterprise Value has changed -134.16% with respect to the historical average. Over the past ten years (40 quarters), FIXX's Enterprise Value was at its highest in in the March 2019 quarter at 1.05B. The Enterprise Value was at its lowest in in the March 2022 quarter at -50012921.60.

Quarterly (TTM)
Annual

Average

371.71M

Median

316.34M

Minimum

-17104204.40

Maximum

818.06M

Homology Medicines, Inc. (FIXX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Homology Medicines, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 36.30%

Maximum Annual Enterprise Value = 818.06M

Minimum Annual Increase = -136.56%

Minimum Annual Enterprise Value = -17104204.40

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024-17104204.40-136.56%
202346.79M-36.05%
202273.16M-57.94%
2021173.96M-45.01%
2020316.34M-61.33%
2019818.06M36.30%
2018600.20M-7.22%
2017646.88M-5.85%

Homology Medicines, Inc. (FIXX) Average Enterprise Value

How has FIXX Enterprise Value performed in the past?

The current Enterprise Value of Homology Medicines, Inc. (FIXX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

34.28M

5-year avg

118.63M

10-year avg

371.71M

Homology Medicines, Inc. (FIXX) Enterprise Value vs. Peers

How is FIXX’s Enterprise Value compared to its peers?

Homology Medicines, Inc.’s Enterprise Value is less than Affimed N.V. (8.02M), less than RVL Pharmaceuticals plc (16.09M), greater than Aravive, Inc. (-44467140.00), greater than Idera Pharmaceuticals, Inc. (-11484000.00), less than Eiger BioPharmaceuticals, Inc. (28.35M), less than GeoVax Labs, Inc. (-971761.00), less than Atreca, Inc. (36.62M), less than Biophytis S.A. (8.17M), less than Gritstone bio, Inc. (43.29M), greater than Novan, Inc. (-5749751.00),

CompanyEnterprise ValueMarket cap
8.02M$2.98M
16.09M$3.14M
-44467140.00$2.95M
-11484000.00$0
28.35M$12.59M
-971761.00$4.04M
36.62M$3.57M
8.17M$2.61M
43.29M$3.80M
-5749751.00$2.64M

Build a custom stock screener for Homology Medicines, Inc. (FIXX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Homology Medicines, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Homology Medicines, Inc. (FIXX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Homology Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Homology Medicines, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Homology Medicines, Inc. (FIXX)?

What is the 3-year average Enterprise Value for Homology Medicines, Inc. (FIXX)?

What is the 5-year average Enterprise Value for Homology Medicines, Inc. (FIXX)?

How does the current Enterprise Value for Homology Medicines, Inc. (FIXX) compare to its historical average?